NCT06270836Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

Study sponsor: Kodiak Sciences Inc · KOD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-02-13Actual
Enrollment · participants255Actual
Source updated2026-05-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 31 Jan 2026. After: 13 Feb 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview